Skip to content

The Randomised Uterine Septum Transsection Trial

The Randomised Uterine Septum Transsection Trial - TRUST

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37108
Enrollment
68
Registered
2008-11-03
Start date
2010-10-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septate uterus uterine septum

Interventions

Random allocation to hysteroscopic metroplasty or no intervention.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The trial will study women with a history of recurrent miscarriage or pregnancy loss before 20 weeks of gestational age and/or subfertility and a septate uterus. Recurrent miscarriage is defined as two or more, not necessarily consecutive, pregnancy losses before 20 weeks of gestational age. Subfertility is defined as the inability to conceive for a minimal period of one year. Only women with an active wish to conceive will be eligible.

Exclusion criteria

Exclusion criteria: Prior inclusion in the TRUST study. Contraindications for surgery.

Design outcomes

Primary

MeasureTime frame
Primary outcome is live birth rate in each treatment group.

Secondary

MeasureTime frame
Secondary outcomes are complications following hysteroscopic metroplasty; uterine perforation, fluid overload, endometritis, clinical pregnancy and miscarriage. In a subsequent pregnancy, we will look at the prevalence of adversary pregnancy outcomes, placental abruption, premature delivery, uterine rupture, and mode of delivery (vaginal vs. caesarean section).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)